drugset / Trial / NCT02767947

Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis

NCT02767947

Phase 4 Completed 75 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study was to evaluate the safety, efficacy, and pharmacokinetics of luliconazole cream 1% when applied topically for 7 days in pediatric participants 2 years to 17 years of age (inclusive) with tinea corporis.

Timeline

Start
2016-02-08
Primary completion
2016-06-29
Completion
2016-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Luliconazole Small molecule 1 % Topical

Indications